Establishment Labs is a medical technology company focused on women’s health, principally breast aesthetics and reconstruction. Its flagship Motiva silicone gel implants feature proprietary SmoothSilk surface technology and Ergonomix designs intended to move more like natural tissue. Products are sold globally to plastic surgeons and healthcare providers, with a growing presence in major markets including the United States.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 41.4 | — | -20.7 | — |
| Q2 2025 | 51.3 | — | -16.6 | — |
| Q3 2025 | 53.8 | — | -11.2 | — |
| Q4 2025 | 64.6 | — | -2.6 | — |
| Q1 2026 | 59.9 | 44.7% | -13.4 | — |
| Q2 2026 | 67.5 | 31.7% | -11.8 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Sunrun Inc. (RUN), Formula Systems (1985) Ltd. (FORTY), Alamar Biosciences, Inc. (ALMR), Intuitive Machines, Inc. (LUNR), Palvella Therapeutics, Inc. (PVLA), BlackLine, Inc. (BL)